Filing metadata

Accession number
0001479290-21-000045
Form type
Form 4
Filer
Revance Therapeutics, Inc.
CIK
CIK 1479290
Filed
Feb 19, 2021
Reporting period
Feb 15, 2021
Description
Insider transaction

Explore SEC Filings Hub